All insights

16 November 2026 · Updated 16 November 2026

ShareWhatsAppLinkedIn
In forceLaw stated as on 16 November 2026

By Avil Rakshith Salins, Practising Company Secretary

Convertible Note, CCPS, CCD or Priced Equity: How Indian Startups Should Choose

Convertible Note, CCPS, CCD or Priced Equity: How Indian Startups Should Choose

This article sets out the four instruments an Indian startup can realistically use, what each actually requires, and a decision tree that gets you to the right one in about five questions.

The decision nobody makes deliberately

Most founders do not choose a fundraising instrument. They inherit one. The investor's template arrives, somebody says "let's just do a convertible note", and four weeks later a company secretary discovers that the money cannot lawfully come in that form.

The choice is worth ten minutes of thought, because it is the one decision in a fundraise that is genuinely hard to reverse. Terms can be renegotiated. Valuations can be argued. But once money has landed under the wrong instrument, unwinding it means refunds, rescinded resolutions and an awkward conversation with the investor who thought the deal was done.

The four instruments, one line each

Priced equity. You agree a valuation today and the investor buys shares at that price. Clean, final, and only possible if a price can be agreed.

CCPS — compulsorily convertible preference shares. Share capital from day one, carrying preference rights, converting into equity on agreed terms. The institutional default in India.

CCD — compulsorily convertible debentures. Debt that must convert into shares within ten years. Useful where the money needs to behave like debt for a while.

Convertible note. Debt that converts at a price fixed by your next round, subject to a cap. Only available to DPIIT-recognised startups, only for Rs. 25 lakh or more, only in a single payment.

There is a fifth thing people ask for — a SAFE — which has no counterpart in Indian company law. If an investor sends you one, it has to be rebuilt as one of the four above before anyone signs.

The comparison

Priced equityCCPSCCDConvertible note
What it is in lawShare capitalShare capitalDebt until conversionDebt until conversion
Price fixedAt issueAt issueUsually at issueAt the next round
Minimum amountNoneNoneNoneRs. 25 lakh per investor
Single payment requiredNoNoNoYes
DPIIT recognition neededNoNoNoYes
Deposit riskNoneNoneCarve-out, Rule 2(1)(c)(ix)Carve-out, Rule 2(1)(c)(xvii)
Valuation report at issueRequiredRequiredRequired if pricedNot required
Voting rights before conversionYes, fullLimited, Section 47(2)NoneNone
Liquidation preferenceNoYesRanks as debtRanks as debt
Return before conversionDividend if declaredPreference dividendInterestNominal interest
RegisterMembers, MGT-1Members, MGT-1Debenture-holders, MGT-2Debenture-holders, MGT-2
CertificateSH-1, 2 monthsSH-1, 2 monthsNo prescribed form, 6 monthsNo prescribed form, 6 months
Stamp duty on issue0.005%, Art. 56A0.005%, Art. 56A0.005%, Art. 27(a)0.005%, Art. 27(a)
Realistic timeline4-6 weeks3-5 weeks3-4 weeks2-3 weeks

All four go through the same private placement machinery in Section 42 and Rule 14 — board resolution, special resolution, MGT-14 filed before the offer letter, PAS-4, PAS-5, money into a separate account, allotment, PAS-3 within fifteen days. That part does not vary, and it is where most files come apart whichever instrument you pick.

Question 1 — Can you agree a price?

This is the fork everything else hangs off.

If yes, use priced equity or CCPS. A price means a valuation report under Rule 13, a clean cap table, and no deferred argument. Your investor knows exactly what they own on the day the money lands, and so do you.

If no, you need an instrument that defers the price — a convertible note, or a CCD with a conversion formula rather than a fixed ratio.

Be honest about which situation you are in. "We can't agree a price" sometimes means "we haven't tried". Deferring a valuation is not free: you are handing the pricing decision to whoever leads your next round, and accepting a cap that will cost you more the better you do.

Question 2 — How much, and from how many people?

The convertible note has a hard floor: Rs. 25 lakh or more from each investor, in a single payment. Tested per person, not per round.

So an angel round of six people at Rs. 10 lakh each cannot be done on notes. Not six notes, not one note. The carve-out in Rule 2(1)(c)(xvii) does not reach any of them, and money taken outside it is a deposit under Chapter V — credit rating, deposit insurance, repayment reserve, trustees, none of which a seed-stage company can do.

Below Rs. 25 lakh a head, your options are CCPS, CCDs or priced equity. All three work at any amount.

The single-payment condition catches people out even above the floor. If an investor commits Rs. 1 crore to be drawn Rs. 40 lakh now and Rs. 60 lakh on a milestone, one note for Rs. 1 crore breaks. The structure that works is one note per instalment, each of Rs. 25 lakh or more, each with its own offer letter, allotment and filing. Build it in at drafting; discovered afterwards it cannot be fixed.

Question 3 — Is your investor a fund?

Institutional investors generally want CCPS, and for a reason: a liquidation preference. If the company is sold for less than expected, preference shares come out first.

A convertible note holder ranks as a creditor, which sounds better but usually is not — the note typically converts immediately before a sale, at which point they are an ordinary shareholder like everyone else. A CCPS holder keeps a preference that bites in exactly the scenario they are worried about.

A fund will also want anti-dilution protection, information rights, affirmative vote items and an exit mechanism. Those sit naturally in CCPS terms and awkwardly in a two-page note.

The practical rule: angels and micro-VCs take notes. Funds writing institutional cheques take CCPS. If a fund is asking for a note, it is usually because the round is a bridge, not a round.

Question 4 — Is your investor outside India?

This one has a trap in it that catches companies every year.

Under the Foreign Exchange Management (Non-debt Instruments) Rules, 2019, an instrument counts as equity for foreign investment purposes only if it is compulsorily convertible. Equity shares, CCPS and CCDs qualify. Convertible notes have their own express route for recognised startups, with the same Rs. 25 lakh single-tranche floor, reported in Form CN on the FIRMS portal within thirty days of issue.

Anything optionally convertible is debt, which means external commercial borrowings — eligibility criteria, end-use restrictions, all-in-cost ceilings and a borrowing framework no early-stage company can satisfy. An OCPS or OCD issued to a non-resident is not a softer version of a CCPS. It is a different regime, and usually a contravention.

Also note: citizens of and entities incorporated in Pakistan and Bangladesh cannot invest at all, and investors from countries sharing a land border with India need prior government approval under Press Note 3 of 2020, which in practice catches Chinese and Hong Kong capital — including through intermediate holding structures.

Published commentary on the FEMA treatment of convertible notes is unreliable; a good deal of it still cites the superseded 2017 regulations and a five-year conversion window. Confirm the position against the current notification for your specific investor rather than relying on an article.

Question 5 — Do you need a valuation report?

This is where the instruments genuinely diverge, and it affects both cost and timeline.

Priced equity and CCPS — yes. A preferential allotment under Section 62(1)(c) read with Rule 13 of the Companies (Share Capital and Debentures) Rules, 2014 requires a registered valuer's report, and the price cannot be below the valuation. Budget a week or two and a professional fee.

CCD — required where the conversion price or ratio is determinable at issue.

Convertible note — not required at issue. The conversion price is not determinable on the date of the offer letter; it is fixed later by reference to the cap and the next round's price. This is a real advantage in speed.

At conversion, all of them benefit from the same provision — but only if you set it up correctly. The proviso to Section 62(3) allows a company to convert a debenture into shares where the terms were approved by special resolution before the loan was raised. Get that recital into the issue resolution and conversion needs only a board resolution: no fresh special resolution, no fresh valuation. Leave it out and conversion has to come back through Section 62(1)(c) with a new valuation at a price you no longer control.

One line in one resolution, worth a great deal three years later.

On angel tax: Section 56(2)(viib), which taxed share premium above fair value, was omitted with effect from assessment year 2025-26. Pricing a round above fair value is no longer the exposure it was. Earlier years remain open to assessment, so if you have raised before, ask your CA where you stand.

What each one actually costs you in compliance

Priced equity / CCPSCCDConvertible note
Valuation reportYesIf pricedNo
Special resolutionYesYesYes, one per offer
MGT-1430 days, before PAS-4SameSame
PAS-4 and PAS-5YesYesYes
Separate bank accountYesYesYes
Allotment deadline60 days60 days60 days
PAS-315 days15 days15 days
RegisterMGT-1, membersMGT-2MGT-2, 7 days
CertificateSH-1, 2 months6 months6 months
DPT-3Not applicableYes, 30 JuneYes, 30 June
Debenture redemption reserveNot applicableNone, if fully convertibleNone
Demat under Rule 9BIf not a small companySameSame

The compliance load is more similar than founders expect. The real differences are the valuation report, the register that has to be maintained, and — for the note alone — the eligibility gate.

Four traps

Optionally convertible anything. For a non-resident it is ECB, as above. For a resident, an optionally convertible debenture does not fit the Rule 2(1)(c)(ix) carve-out, which requires compulsory conversion within ten years — so it is a deposit. "Optional" sounds like flexibility. It is almost always a contravention.

The imported SAFE. No Indian equivalent. A SAFE is not debt, which the convertible note definition requires, and it can sit outstanding forever, which the ten-year rule forbids. Rebuild it before signing, not after.

Issuing shares cheaply to a friendly investor. A preferential allotment has to be at or above the valuer's price. You cannot do a founder a favour on price without a problem.

The director's loan used as a bridge. A different carve-out with different conditions — the director must declare the money is not borrowed, and the company must disclose it in the Board's report. It is a legitimate stopgap, not a substitute for a round, and it does not convert into anything without going through Section 62(3) properly.

The decision tree

  • 1. Is the investor non-resident? Then the instrument must be compulsorily convertible, or a convertible note under the startup route. Never optionally convertible.
  • 2. Can you agree a price today? If yes, priced equity or CCPS. If no, go on.
  • 3. Is each investor putting in Rs. 25 lakh or more, in one payment? If no, CCPS or CCD. If yes, go on.
  • 4. Is the company DPIIT-recognised, with the certificate valid today? If no, CCPS or CCD. If yes, go on.
  • 5. Does the investor need a liquidation preference or governance rights? If yes, CCPS. If no, a convertible note.

Five questions. Ten minutes. Settle it before the term sheet, not after the money.

Three worked situations

An angel putting in Rs. 15 lakh. Below the note floor, so a note is out. CCPS if they want a preference, CCDs if they are content to sit as debt and convert later, priced equity if a valuation can be agreed. For a single small angel, CCPS is usually cleanest.

A micro-VC putting in Rs. 50 lakh as a bridge to a Series A expected next year. A convertible note fits well, assuming DPIIT recognition is live and the money can come in one payment. No valuation report, fastest route, price deferred to the lead who will actually set it.

A fund putting in Rs. 5 crore as a priced round. CCPS. Valuation report, liquidation preference, anti-dilution, shareholders' agreement. A note would be the wrong instrument even if it were technically available.

Before the term sheet

  • DPIIT recognition status and expiry date confirmed
  • Each investor's cheque size known, and whether it comes in one payment
  • Investor residency confirmed, and Press Note 3 checked if relevant
  • Whether a liquidation preference is being asked for
  • Whether a valuation report is needed, and lead time allowed for it
  • Articles checked — do they permit preference shares, and do they permit the issue of debentures?
  • A separate bank account with a scheduled bank, opened
  • If Rule 9B demat applies to you, the ISIN started

Settle the instrument before terms are drafted. Everything downstream — the resolutions, the offer letter, the registers, the filings — follows from that one choice, and changing it afterwards means starting again.

Law referred to: Companies Act, 2013 — Sections 42, 47(2), 55, 56, 62 and 71; Companies (Prospectus and Allotment of Securities) Rules, 2014 — Rules 9B and 14; Companies (Acceptance of Deposits) Rules, 2014 — Rule 2(1)(c)(ix) and (xvii); Companies (Share Capital and Debentures) Rules, 2014 — Rules 9, 13 and 18; Indian Stamp Act, 1899 — Articles 27(a) and 56A of Schedule I; Foreign Exchange Management (Non-debt Instruments) Rules, 2019; Income-tax Act, 1961 — Section 56(2)(viib) as omitted.

General information, not advice on any particular transaction. Take advice on your own facts before acting.

Frequently asked questions

Then the instrument must be compulsorily convertible, or a convertible note under the startup route. Never optionally convertible.

If yes, priced equity or CCPS. If no, go on.

If no, CCPS or CCD. If yes, go on.

If no, CCPS or CCD. If yes, go on.

If yes, CCPS. If no, a convertible note.
ShareWhatsAppLinkedIn

Engage the practice

Discuss this with a practising Company Secretary.

Thirty minutes to map your obligations and decide whether the practice is the right fit for your matter.